Treg cells migration into the tumor microenvironment is mediated by the CCL5/CCR5 axis in pancreatic adenocarcinoma, and blockade of this pathway may represent a novel immunomodulatory strategy for the treatment of cancer. This evidence concerns the gene CCR5 and neoplasm.